Minghuan Li

6PUBLICATIONS
1CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 16, 2026
Spleen volume change as a prognostic and immunologic imaging biomarker in extensive-stage small-cell lung cancer receiving chemo-immunotherapy.

Xiuli Liu, Ao Liu, Defeng Liu

|Feb 23, 2025
Postoperative Adjuvant Therapy Benefits Non-pCR Patients Rather Than pCR Patients for Locally Advanced ESCC: A Multicenter Real-World Study.

Defeng Liu, Ao Liu, Longxiang Guo

|Feb 14, 2025
The Role of Lymphocyte Recovery Index in Prognosis Prediction for Locally Advanced Cervical Cancer With Radiation-Induced Lymphopenia.

Yi Li, Ao Liu, Xin Wang

|Feb 06, 2025
The Combined Prognostic Value of 18F-FDG PET/CT Metabolic Parameters of Immune Organs and Hematological Immune-Related Markers in Patients With Locally Advanced Cervical Cancer.

Yi Li, Xin Wang, Yuanlin Li

|Mar 14, 2024
The role of spleen radiomics model for predicting prognosis in esophageal squamous cell carcinoma patients receiving definitive radiotherapy.

Longxiang Guo, Ao Liu, Xiaotao Geng

|Jul 07, 2020
Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy.

Zongxing Zhao, Yanan Zhang, Xin Wang

Pageof 1

Frequent Collaborators

1 joint publications

Jinming Yu